RASGRP2 and myeloid sarcoma: Interestingly, a similar cross-reactivity has previously been demonstrated for CD4+ T cells in the context of MS, with some CD4+ T cells recognizing the RASGRP2 antigen expressed by B cells and cortical neurons40.